Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Winnergy Medical PCLBKK:WINMED -2.94%75 5-Year Yield-on-Cost % is 0.92 as of Sep. 15, 2026, which is 43% below its 10-year median of 1.61. GuruFocus rates BKK:WINMED with a GF Score™ of 75/100 and a GF Value™ of ฿1.46 (Modestly Undervalued). The stock has 15 warning signs investors should review. Among 71 Medical Distribution companies, Winnergy Medical PCL ranks worse than 87.32% on this metric.
Winnergy Medical PCL's yield on cost for the quarter that ended in Jun. 2026 was 0.92.
The historical rank and industry rank for Winnergy Medical PCL's 5-Year Yield-on-Cost % or its related term are showing as below:
BKK:WINMED'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.92 Med: 1.61 Max: 2.87
Current: 0.92
During the past 10 years, Winnergy Medical PCL's highest Yield on Cost was 2.87. The lowest was 0.92. And the median was 1.61.
BKK:WINMED's 5-Year Yield-on-Cost % is ranked worse than 87.32% of 71
companies
in the Medical Distribution industry
Industry Median: 3.17
vs BKK:WINMED: 0.92
Winnergy Medical PCL (BKK:WINMED) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Winnergy Medical PCL 5-Year Yield-on-Cost % Related Terms
BKK:WINMED vs MCK, COR, CAH: 5-Year Yield-on-Cost % Comparison
For the Medical Distribution subindustry, Winnergy Medical PCL's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Winnergy Medical PCL 5-Year Yield-on-Cost % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Winnergy Medical PCL's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Winnergy Medical PCL's 5-Year Yield-on-Cost % falls into.
Winnergy Medical PCL 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Winnergy Medical PCL (BKK:WINMED) has a 5-Year Yield-on-Cost % of 0.92 as of Sep. 15, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Winnergy Medical PCL and its competitors. This is 43% below median its historical median of 1.61. Over the past decade, Winnergy Medical PCL's 5-Year Yield-on-Cost % has ranged from 0.92 to 2.87. According to the industry distribution chart, Winnergy Medical PCL ranks #62 out of 71 companies in the Medical Distribution industry, placing it in the top 87.3%.
Is Winnergy Medical PCL's 5-Year Yield-on-Cost % too high?
Winnergy Medical PCL's current 5-Year Yield-on-Cost % of 0.92 is 43% below median its 10-year median of 1.61. Over the past 10 years, this metric has ranged from a low of 0.92 to a high of 2.87. The Medical Distribution industry median 5-Year Yield-on-Cost % is 3.17. Winnergy Medical PCL's value of 0.92 is 71% below this industry median. Based on the distribution chart, Winnergy Medical PCL ranks #62 out of 71 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Winnergy Medical PCL has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Winnergy Medical PCL's 5-Year Yield-on-Cost % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Winnergy Medical PCL ranks #62 out of 71 companies for 5-Year Yield-on-Cost %. This places Winnergy Medical PCL in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 3.17. Winnergy Medical PCL's value of 0.92 is 71% below this benchmark. Historically, Winnergy Medical PCL's own 5-Year Yield-on-Cost % has ranged from 0.92 to 2.87 over the past decade. While the company's 10-year median is 1.61 vs. the industry median of 3.17, Winnergy Medical PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Distribution company?
The median 5-Year Yield-on-Cost % among Medical Distribution companies is 3.17, based on 71 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Winnergy Medical PCL's current 5-Year Yield-on-Cost % of 0.92 is 71% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Winnergy Medical PCL and its competitors. For the Medical Distribution industry, the median 5-Year Yield-on-Cost % is 3.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Winnergy Medical PCL's current 5-Year Yield-on-Cost % is 0.92, which is 43% below median its own 10-year median of 1.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Winnergy Medical PCL stock overvalued right now?
Based on GuruFocus' analysis, Winnergy Medical PCL (BKK:WINMED) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿1.46, compared to a current price of ฿1.32 — trading 9.6% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.92, which is 43% below median its 10-year median of 1.61 and 71% below the Medical Distribution industry median of 3.17. Winnergy Medical PCL's overall GF Score™ is 75/100 with 15 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Winnergy Medical PCL (BKK:WINMED), the current 5-Year Yield-on-Cost % is 0.92 as of Sep. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Winnergy Medical PCL (BKK:WINMED) Overvalued in 2026?
Based on GuruFocus' analysis, Winnergy Medical PCL stock appears to be undervalued.
The current stock price of ฿1.32 is trading 9.6% below its estimated GF Value™ of ฿1.46.
GuruFocus considers Winnergy Medical PCL to be Modestly Undervalued.
Key valuation signals for BKK:WINMED:
5-Year Yield-on-Cost %: 0.92 (43% below median its 10-year median of 1.61)
GF Value™: ฿1.46 vs. price of ฿1.32 (9.6% below fair value)
Industry Position: 71% below the Medical Distribution median (#62 of 71)
No single metric tells the full story. See the BKK:WINMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Winnergy Medical PCL is engaged in the distribution of medical and diagnostics equipment. Its businesses include the distribution of medical devices, chemicals, and medical equipment and technology. The company operates in the geographic area of Thailand.
75GF Score
Get the complete analysis for BKK:WINMED
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:WINMED has been successfully added to your 
